<DOC>
	<DOCNO>NCT00545025</DOCNO>
	<brief_summary>The protocol design demonstrate safety influenza vaccine GSK1247446A revaccination .</brief_summary>
	<brief_title>Revaccination With Influenza Vaccine GSK1247446A</brief_title>
	<detailed_description>The Protocol Posting update order comply FDA Amendment Act , Sep 2007 .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female age 1860 year old time vaccination , previously participate 108656 clinical trial . Subjects investigator believe comply requirement protocol . Written inform consent obtain subject . Free obvious health problem establish medical history clinical examination enter study . If subject female , must nonchildbearing potential , childbearing potential , must abstinent use adequate contraceptive precaution 30 day prior vaccination , negative pregnancy test must agree continue precaution two month completion vaccination series . Use investigational nonregistered product ( drug vaccine ) study vaccine within 30 day precede administration study vaccine , plan use study period . Planned administration influenza vaccine study vaccine entire study period Previous vaccination influenza since January 2007 . Acute chronic clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine physical examination laboratory screen test . Chronic administration immunosuppressant immunemodifying drug within three month prior first vaccine dose . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination Administration immunoglobulins and/or blood product within three month precede dose study vaccine plan administration study period . History hypersensitivity previous dose influenza vaccine . History confirm influenza infection within last 12 month . Pregnancy . History allergy reaction likely exacerbate component vaccine ( ) Acute disease time enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Influenza vaccine</keyword>
</DOC>